header logo image


Page 30«..1020..29303132..40..»

Archive for September, 2020

GenSight Biologics Submits EU Marketing Authorisation Application for LUMEVOQ Gene Therapy to Treat Vision Loss Due to Leber Hereditary Optic…

Tuesday, September 15th, 2020

Sept. 15, 2020 05:30 UTC

PARIS--(BUSINESS WIRE)-- Regulatory News:

GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced that it has submitted the Marketing Authorisation Application (MAA) for its lead product LUMEVOQ to the European Medicines Agency (EMA), seeking approval for the treatment of patients with vision loss due to Leber Hereditary Optic Neuropathy (LHON) caused by mutation in the ND4 mitochondrial gene.

This first regulatory submission for GenSight is a major milestone in our progression from a pure research organization to one with commercial capabilities. It validates a technology platform that has the potential to address the high unmet medical needs of patients suffering from a range of rare diseases. I would like to thank all GenSight employees and partners whose motivation, focus and effort made this submission possible, said Bernard Gilly, Co-founder and Chief Executive Officer of GenSight Biologics.

LHON is a rare, mitochondrial genetic disease, mainly affecting young males. The ND4 mutation results in the worst visual outcomes, with most patients becoming legally blind. There continues to be a high unmet medical need for the 800-1200 new LHON patients in Europe and the U.S. each year, particularly those who are struck blind in their prime working years.

Lenadogene nolparvovec (tradename: LUMEVOQ) is a recombinant adeno-associated viral vector, serotype 2 (rAAV2/2), containing a cDNA encoding the human wild-type mitochondrial NADH dehydrogenase 4 protein (ND4), which has been specifically developed for the treatment of LHON associated with mutation in the ND4 gene. It received orphan drug designation status for the treatment of LHON from the EMA in 2011 and from the U.S. Food and Drug Administration (FDA) in 2013.

GenSight submitted the MAA based on the benefit-risk balance established by results from a Phase-I/IIa study (CLIN-01), two pivotal Phase-III efficacy studies (CLIN-03A: RESCUE, and CLIN-03B: REVERSE) and the long-term follow up study of RESCUE and REVERSE (CLIN 06 - readout at Year 3 post injection). To demonstrate the efficacy of LUMEVOQ in the context of a contralateral effect, the Company used a statistics-based indirect comparison methodology to assess the visual outcomes in LUMEVOQ-treated patients (from LUMEVOQ efficacy studies) against those in untreated patients from Natural History studies and GenSights REALITY Natural History Registry.

GenSight expects to submit the Biologics License Application (BLA) for LUMEVOQ to the FDA in H2 2021. First-in-human data from GenSights second clinical stage program, GS030, are expected to be available in H2 2021.

About GenSight Biologics GenSight Biologics S.A. is a clinical-stage biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders. GenSight Biologics pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics to help preserve or restore vision in patients suffering from blinding retinal diseases. GenSight Biologics lead product candidate, LUMEVOQ (GS010; lenadogene nolparvovec), is in Phase III trials in Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible blindness in teens and young adults. Using its gene therapy-based approach, GenSight Biologics product candidates are designed to be administered in a single treatment to the eye by intravitreal injection to offer patients a sustainable functional visual recovery.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200914005857/en/

More:
GenSight Biologics Submits EU Marketing Authorisation Application for LUMEVOQ Gene Therapy to Treat Vision Loss Due to Leber Hereditary Optic...

Read More...

Severance uses radiotherapy to treat ocular cancer while saving eyesight – Korea Biomedical Review

Tuesday, September 15th, 2020

A research team at Severance Hospital said Thursday that the hospital has begun to treat ocular cancer patients by introducing the Ru-106 eye plaque brachytherapy, which can preserve patients eyesight.

Ru-106 eye plaque brachytherapy removes tumors with irradiation by attaching a plate with ruthenium isotope that emits radiation to the patients' eyeball. The metal plate is removed within seven days after surgery, the hospital said.

The existing surgical methods had to remove the eyeball and replace it with a prosthetic eye. However, the Ru-106 eye plaque brachytherapy preserves the eye and keeps a certain level of vision. According to the research team led by Professors Kim Min and Cho Yeon-a, patients can return to their daily lives relatively quickly as the treatment only takes about a week.

Brachytherapy, a type of internal radiation therapy, is most effective in treating uveal melanoma. Uvea is a layer sandwiched between sclera and retina. It got the name uvea from its black grape-like appearance. Uveal melanoma, a malignant tumor in the uvea, had to be treated by removing the eyeball or external beam radiation.

"Patients with retinoblastoma, which is commonly developed in children, can also be treated with the Ru-106 to preserve eyesight with limited effect," said Professor Kim Min of the Department of Ophthalmology at Severance Hospital. Professor Kim completed his training for one year at Wills Eye Hospital, one of the world's leading eye cancer institutions, and treated about 10,000 patients with eye tumors.

Professor Cho of the Department of Radiology Oncology recently published a paper on the effectiveness of brachytherapy for eye tumors and the possibility of conserving the eye.

Read more here:
Severance uses radiotherapy to treat ocular cancer while saving eyesight - Korea Biomedical Review

Read More...

Midland Eye Associates eying expansion plan – Midland Daily News

Tuesday, September 15th, 2020

Jon Becker, For the Daily News

Midland Eye Associates eying expansion plan

Midland Eye Associates has been serving the Mid Michigan community for more than 80 years and clearly has a vision for growing a practice that is recognized as a leader in its field. Already equipped with the latest and greatest in technology and led by two highly regarded optometrists, Dr. Carl Erickson and Midland native Dr. Paul Kimball, the practice is in a period of transition as it embarks on an ambitious expansion plan that will allow it to offer more services to more people.

A two-time Gold award winner in the Midland Daily News 2020 Readers Choice awards, Midland Eye Associates specializes in providing comprehensive primary vision care for all members of your family.

Our employees care about people, said Erickson. We have 10 people currently on staff that we feel strongly are second to none.

And its not just the technical knowledge of everything eyes that sets the practice apart. After a recent appointment, a senior citizen discovered it was pouring rain as she was about to exit the building. One of the staff members walked the woman out with an umbrella and held the doors open for her, a gesture that was very much appreciated.

We believe in customer service and being up-front and transparent with people, said Erickson, an honors graduate of the Michigan College of Optometry where he earned his doctorate of Optometry.

Midland Eye Associates is located at 217 N. Saginaw Road, an area that Erickson noted is ripe for investment. The practices plan to increase its physical footprint from 2,000 square feet to 5,500 square feet has been delayed but not derailed by COVID-19.

We should start demo in about two to three weeks, said Erickson. We now have three exam lanes. Once the project is completed, well have 9 exam lanes and will be able to increase services.

Erickson said the building expansion is an investment in the community that the City of Midland supports.

I think the city sees this corridor as the next area it would like to further develop, he said. It meets their criteria for an improved business corridor. Dr. Kimball was born and raised in Midland, so hes certainly happy to see whats in the works here.

Complete examinations at Midland Eye Associates include digital photo documentation of your eyes, testing for glaucoma, cataracts and other medical eye health issues. The eye doctors point out that conditions such as high blood pressure and diabetes can affect eyesight.

We monitor and watch for changes in your eye health, and give you the best vision care possible, said Erickson. Routine eye exams are our bread and butter, but we offer a number of other services. Were a medically-oriented practice.

Glaucoma management care, macular degeneration care, cataracts (pre-op and post-op) diabetic management care and treating red-eyes and foreign bodies are among his specialties.

A new emerging trend is myopia contacts that are used for near-sightedness, he said. They reduce the risk for retina detachments and glaucoma. This is a service we have that is mainly kid-based.

Staying on the cutting edge of technology and a commitment to continuing education are hallmarks of a practice set in a welcoming and family-friendly atmosphere.

Our dedicated team is definitely what sets us apart, said Erickson. Customers tell Dr. Kimball and me all the time how much they appreciate our friendly and courteous service.

These customers certainly weighed in when it was time to rate local optometrists in the categories of best eyewear and best eye doctor.

Right now, with the pandemic still with us, these honors are kind of humbling, said Erickson. People are on edge and yet still took the time to recognize us. These are whole team awards.

Go here to see the original:
Midland Eye Associates eying expansion plan - Midland Daily News

Read More...

I went blind overnight at the age of 29 it turned out to be leukaemia that had turned my blood to – The Sun

Tuesday, September 15th, 2020

A POLICE officer lost his eyesight overnight after leukaemia turned his blood to porridge.

George Attwood had been working a night shift when his vision became blurry.

7

The officer was unable to read number plates or see what was on his laptop screen - no matter how close he was.

The 29-year-old contacted his GP in Dorset who told him he should go and see an optician for an eye test.

The fit and active officer who serves with Wiltshire Police then booked an appointment at Specsavers.

He was unable to read just one letter from the top line of the opticians chart.

George was taken to Bournemouth Hospital and after undergoing blood tests, it emerged that George had suffered bleeds at the back of his eyes.

It was then that George was given the news that he was suffering from leukaemia.

Doctors explained to George that the bleed had caused a high blood count that made his blood thick and porridge-like.

7

Chances are the bleeds at the back of my eyes were caused by my blood, which they said was a bit like porridge and was so thick because of all the white blood cells

Within hours of being admitted to, George started a gruelling 10-day cycle of chemotherapy.

George is now set for three more rounds of treatment and has relived the horror of his ordeal.

George, from Verwood, Dorset, said: "After the optician told me I'd had a bleed at the back of my eyes I was quite tearful.

"I got back into the car and I broke down and told my girlfriend what they said.

"I remember thinking 'if I can't see, what can I do? Your eyes are so important, I can't drive or do my job'.

"When my GP contacted me asking to go in for some blood tests I assumed it was a routine check-up, but never in a million years did I consider it to be leukaemia.

He said that at first the news didnt sink in and added that he was in total disbelief.

What is Leukaemia?

Leukaemia is a type of blood cancer which effects cells in bone marrow and attacks the immune system.

The disease is often classified as what type of cell is affected (myeloid or lymphatic) and how it progresses (acute or chronic).

Acute leukaemia is when it is progressing aggressively and requires immediate attention.

The risk of developing acute myeloid leukaemia (AML) increases with age, with the cancer being most common in adults over 65.

Typically the symptoms of AML can become increasingly more severe over time.

According to theNHS website, the signs to look out for include:

Speak to a GP if you or your child have possible symptoms.

I didn't believe that this would happen to me.

"I've never been sick before, I've never had to go to hospital for anything.

"It wasn't until the Thursday when I woke up in hospital and the chemotherapy started that it really sank in, I was in a real state of shock."

George, who was previously a ministry of defence police officer, said he started to feel unwell at the start of July.

He said he suffered from a sore throat and had a coronavirus test to check he hadnt contracted the virus.

It came back negative and he was given penicillin, but when the course finished his sore throat came back and he started to suffer from sweating.

At this time he put it down to the hot weather.

7

On July 29 George started having issues with his sight and believed he had contracted the coronavirus - remembering Dominic Cummings notorious lockdown trip to Barnard Castle being sight-related.

During his eye test days later on July 31, opticians said he had a bleed behind the eyes.

On August 5, doctors called him and told him he had leukaemia.

George said: "It all started as a sore throat, which made it painful to eat or swallow, then I began to experience breathlessness.

"When I was at work and had to walk up a flight of stairs I would be out of breath at the top, which had never happened before.

"I brushed the breathlessness and sweating I was experiencing off, and just put it down to the hot weather, it was a series of unfortunate events.

"That week I did my annual fitness test for the police and I almost collapsed but still powered on. I've aced all of those in the past and pretty much had 20/20 vision.

7

George added that he was worried it was Covid, but said that being a front line police officer made him feel as though it was inevitable that he would catch it.

"I just hoped I wouldn't catch it horrifically and that youth and fitness was on my side.

"I had two night shifts to work and on the Wednesday [July 29] I lost my vision, it went all blurry, to the point where I couldn't read a number plate while stood next to it let alone 20 metres away.

"The optician said I'd suffered bleeds to the back of the eyes, in the centre field, which was why my vision was all blurry.

"I assumed it was to do with Covid as I'd seen in the papers about Dominic Cummings saying he'd driven to a castle because of eye issues.

"The optician referred me for an urgent referral to the hospital, and because of that my GP did some blood tests.

"As my girlfriend and I were cooking dinner I got a call from the GP saying 'sorry I'm the bearer of bad news, it looks like you've got leukaemia and you need to go to hospital'.

"The doctors at Bournemouth Hospital were amazing, they sat me down and explained what leukaemia was and why I was feeling the way I was."

7

It was at the hospital that doctors told George that the breathlessness had been caused by low blood levels.

George added: "A normal person should have a red blood count of about 120, mine was about 55.

"They then said a normal person should have a white blood count of about 10-20 and mine was 550.

"Chances are the bleeds at the back of my eyes were caused by my blood, which they said was a bit like porridge and was so thick because of all the white blood cells."

George said his sight is slowly improving but added that the chemo has taken a toll on his body.

George said: "At the end of the chemo cycle, I felt very tired but generally felt better.

7

"I could only walk short distances before I had to sit down and I couldn't stand for a full shower was feeling very tired.

"Going from such a fit and active role to that was a real shock to the system."In my old job in the MOD police we were allowed to work out on shift and my girlfriend and I would go for long walks.

"We loved going up Snowdon and were planning to go up Ben Nevis this year as we're really into long-distance walking and hiking.

"I did the Salisbury half marathon in 2018, I've always been a person who can keep going mind over matter.

"Doing that and now suddenly having your body physically shutting down rather than mentally is a big change.

He added that specialists say his eyesight will take months to get better.

"I'm able to watch TV but I'm unable to read books or do puzzle books.

"There's no history of cancer or leukaemia in my family, doctors still don't understand why certain people get it.

"They said the only way to describe it was as bad luck, my family and girlfriend were absolutely distraught.

"I have an amazing support network around me, which is a big help."

George is now keen to raise funds for the ward he has been treated on and praised the staff at Bournemouth Hospital.

7

George said: "The hospital staff have been absolutely phenomenal, from day one they've put me at ease.

"I really want to give back to the ward and the staff because they've been absolutely amazing.

"I noticed some of the fitness equipment was outdated and they have a box full of arts and crafts to give people on the ward.

"I started using some of the stuff and I thought it was a great idea.

"I set up the GoFundMe page for the ward so I could focus on it between treatments and also because I was also getting loads of fundraising offers from people.

"As a police officer you always put yourself out there first, you're there on the front line trying to save people and be there for them. I think people like to give back to people that have done the same.

"I wanted to share my story to inspire people and remind everyone that during these tough times we still need to be focused and thankful for people."

BONUS BALLBBC stars' salaries REVEALED as Zoe Ball gets 1m more after gender pay-gap row

BIG MAC AND FLU2 McDonald's hit by Covid as staff test positive - but branches stay open

PEST AND TRACEWoman shocked as 'creepy' tour bus driver uses test-&-trace data to text her

WARNING SIGNBoozing too much? Take this test to find out if you've got an alcohol problem

'YOU'RE RUINING SPOONS!'Wetherspoons chef shows how they really make curry and breakfasts

EARLY DOORSPubs face 9pm curfew if 'rule of 6' fails to stop rise in Covid infections

Specsavers' clinical services director Giles Edmonds said: "There are several changes we may notice in our vision which could be a sign of a wider health condition, as demonstrated by George's story. If you are experiencing any sudden eye health or vision changes, it's imperative you book an eye appointment so an optician can conduct a thorough examination.

"Your optician will ask if you are experiencing any concerns. Diagnostic testing will then look at the overall health of the eye to reveal any changes or concerns that are not visible to the naked eye.

"With George, swelling in the optic nerves and changes to the appearance of blood vessels behind the eye indicated something serious so he was referred to his local hospital to ensure he was seen quickly and by the right consultant. This is a common unknown fact that an optician can ensure a customer is seen by the right consultant at a hospital when an anomaly is identified.

"At a time when GPs and the NHS are under immense pressure, our opticians remain open to care for urgent cases like George's and to help people avoid busy A&E departments."

Read the original:
I went blind overnight at the age of 29 it turned out to be leukaemia that had turned my blood to - The Sun

Read More...

20% increase in people with heart complications amid Covid: Report – WeForNews

Tuesday, September 15th, 2020

Washington Albert Bourla, the head of pharmaceutical giant Pfizer, which is among the companies developing a coronavirus vaccine, said Sunday there is a good chance the company will know whether its vaccine works by the end of October.

In an interview with Face the Nation, Bourla said its not yet known whether Americans will be able to receive a coronavirus vaccine before 2021, as issuance of a license depends on federal regulators. But studies from Pfizer indicate we have a good chance that we will know if the product works by the end of October.

Still, Bourla said Pfizer is preparing for approval from the federal government and distribution of a vaccine before the end of the year.

We started already manufacturing and we have already manufactured hundreds of thousands of doses, so just in case we have a good study readout, conclusive and FDA, plus the advisory committee feels comfortable that we will be ready, he said.

Pfizer, which has partnered with BioNtech on its coronavirus vaccine, has begun enrolling 30,000 people in its phase three vaccine trial but is looking to expand its enrollment to 44,000. Bourla said the decision to increase the number of participants stems from its desire to expand to more vulnerable populations.

We go to younger people. Right now, the study recruits from 18 to 85. Now we will go to 16 years old, he said. Also, we will go to people with special conditions, chronic conditions like HIV patients, but also we will try to use it to increase the diversity of the population.

While Pfizer is one of several companies currently enrolling participants in its phase three vaccine trial, it is the only U.S.-based pharmaceutical company that has rejected federal dollars for its vaccine candidate.

Bourla acknowledged that if its coronavirus vaccine fails, Pfizer will absorb the financial hit. But he said he decided not to accept government funding for vaccine development to shield the pharmaceutical giant from politics.

I wanted to liberate our scientists from any bureaucracy, he said. When you get money from someone that always comes with strings. They want to see how we are going to progress, what type of moves you are going to do. They want reports. I didnt want to have any of that. I wanted them basically I gave them an open checkbook so that they can worry only about scientific challenges, not anything else. And also, I wanted to keep Pfizer out of politics.

While Bourla stopped short of predicting when Americans may be able to receive a coronavirus vaccine, Dr. Scott Gottlieb, former commissioner of the Food and Drug Administration and a member of Pfizers board of directors, has stressed he does not believe a vaccine will be widely available until 2021.

This is likely to be a very staged market entry, he said on Face the Nation. I think thats what people should expect. But for most people, they will not have access to a vaccine until 2021. I think maybe the first quarter of 2021, probably the first half of 2021. And thats assuming that these vaccines are demonstrated to be safe and effective in these large trials.

If any population in the U.S. is to receive a coronavirus vaccine this year, Gottlieb predicted it will be those who are at a high risk of becoming very sick from the virus or frontline workers who are at a high risk of contracting it.

What were going to be doing is targeting the vaccine to select groups of people who are at very high risk of a bad outcome from COVID to try to reduce their risk, he said. But its not going to be used to achieve broad-based immunity, at least in 2020, perhaps in 2021.

Go here to read the rest:
20% increase in people with heart complications amid Covid: Report - WeForNews

Read More...

Can the flu shot make you sick? – Quartz

Sunday, September 13th, 2020

The intent of flu shots is to avoid the flu. We know this. Its been drilled into our heads again and again. And yet, a little less than half of adults in the US got the routine jab for the 2018 to 2019 flu season. (This was actually a pretty high vaccination rate; in recent flu seasons, adherence has hovered around 40%.)

The reason for this shouldnt be the costmost insurance and Medicaid covers the flu vaccine as preventative medicine. Nor should itbe conveniencethe US passed a law in August allowing pharmacists across all 50 states to give flu shots. Instead, its the myth that the flu shot itself makes you sick.

Like most misconceptions that stick around, theres alittletruth to it. Its normal to feel peakyfatigued, achey, or warm with a low-grade feverafter getting a flu shot. This is the robust immune response as the bodys creating antibodies, actual protection against the flu, says Juanita Mora, an immunologist practicing in Chicago and volunteer medical spokesperson with the American Lung Association. It happens to about 10% of people who get the shot, she says.

In other words, feeling like youre in the early stages of getting the flu is actually a sign that youll be protected from the actual virus. What youre feeling is the bodys defense system gearing up.

Most versions of the flu shot are comprised of inactivated viruses, meaning they cant actually infect your cells. Immune cells, though, fire off chemical alarms as soon as they notice any virus-like particle. They activate the innate immune system, a generalized response that tries to make the body unlivable for any potential pathogen. That inflammatory reaction can cause a bit of a fever or a tiny swollen lump near the injection site.

The fatigue you might feel comes from gearing up a more specialized immune defense. Tiny, specialized cells called B-cells create antibodies, which are cellular fighter pilots specific to each virus. Making these antibodies requires expending a little extra energy at first, but the payoff is future protection: Once theyre present in your plasma, the antibodies can patrol for future flu viruses.

It is possible to get sick after getting the flu shot, Mora says. But it wouldnt be a result of the vaccine itself. If your body was in the early stages of fighting off another kind of infection, like a cold or strep throat, and then you get the shot, your B-cells can get overwhelmed. Instead of making antibodies to fight off the actual infection, they get pulled into making flu antibodies, which leaves you vulnerable to another ailment.

Additionally, it takes about two weeks for your body to whip its flu antibodies into shape; you could pick up a flu strain in the window between getting your jab and when protection kicks in. Thats why its important to make sure you only get a flu shot, or any vaccine, when youre feeling healthy.

Not everyone notices these symptoms after getting the flu shot. But if you do seem a bit off, the feeling shouldnt stick around for more than a day or two, and shouldnt require a visit to your healthcare provider. If you do have a more severe reaction, its worth giving them a callthere could be something else going on.

Read more from the original source:
Can the flu shot make you sick? - Quartz

Read More...

Spain virologists say the countrys second virus wave holds a valuable lesson for the rest of the world – MarketWatch

Sunday, September 13th, 2020

MADRID Just days away from the start of a new school year, Spains capital city rolled out fresh restrictions on Monday to cope with whats becoming a relentless second wave of cases.

But those measures strict controls on the distance between seats rather than tables in food-service settings, reducing funeral attendance to 25 people indoors and 50 outdoors, and 10-person limits on social gatherings seem modest as the countrys total infections close in on 500,000, according to the latest data from Johns Hopkins. Official numbers indicate that threshold has already been reached. Spains is the highest infection total in Europe, though it pales against the 6 millionplus cases in the U.S., which has seven times Spains population.

Madrids new measures are cold comfort to parents, including this journalist, who will be sending at least one child to all-in-person classes of 21 children. More than 2,000 of 66,000 Madrid teachers recently tested positive for COVID-19 and will have to be retested. Elsewhere in the country, two schools have already had to close due to infections.

At the heart of the resurgence of Spains cases has been a rush to return to normal. Spains experience has also been impacted by government desperation to get the tourism industry and bars back in operation; overly relaxed family gatherings; insufficient safety protocols for field workers; and the behavior of idle youth with effectively nothing to do but party, and spread the virus.

Much as New York did, Spain climbed out of the depths of COVID-19 infections with the strictest measures possible, but some parts of the country began to suffer two months later. To be clear, not all of the country has been equally affected in the second wave, with Madrid the hardest hit, while other regions are seeing low infection rates, as this government map shows.

How the country pulls itself out this time may be a blueprint for other countries and municipalities to follow. MarketWatch spoke to these experts via email in hope of shedding light on where Spain stands now and what should be done.

Juan Jess Gestal Otero, professor emeritus of preventative medicine and public health at the University of Santiago de Compostela in Galicia, was one of 20 experts who signed a letter in the British medical journal the Lancet asking for an independent review of Spains COVID-19 response.

MarketWatch: What key mistakes did Spain make after the lockdown in the spring, and what must it do now to fix the situation?

Otero: It took a long time to get contact tracing up and running. It should have started when the case curve began to decline. It would have helped to have the disease more controlled at the end of the de-escalation. Each autonomous community set up its own tracking system, many of them insufficiently staffed.

MarketWatch: Will Madrids new measures, such as cutting capacity at bars and restaurants, really help get the disease under control?

Otero: I dont think those measures help much to contain outbreaks. ... To have the disease under control, the most important thing at this time is to strengthen the tracking capacity of the national health system. If this is not done soon, the continued increase in outbreaks can eventually overwhelm the tracking capacity of the system and lead to a loss of control and aggravate the situation. National coordination is also very important.

Dont miss:To defeat COVID-19, we need a unified national strategy, says public health expert Dr. Howard Koh

MarketWatch: What are the differences between now and March that are encouraging and discouraging?

Otero: Now there is epidemiological surveillance capacity, although it needs much improvement, for the early diagnosis of cases and contact tracing, and there is the capacity to perform many tests, which allows for detection of a large number of asymptomatic patients. Most of the current cases are young people in whom the disease is less severe, unlike in March-April, and the health system is not under pressure. It is discouraging to observe how certain social groups, mostly young people, are encouraging outbreaks with their behaviors.

MarketWatch: What should other countries learn from Spain?

Otero: Strongly strengthen the epidemiological surveillance system. As soon as possible, start tracking the contacts of the cases and carry out many, many tests, to locate the largest possible number of asymptomatic patients. Make the return to the new normal very carefully to avoid new outbreaks. Do not authorize activities that are incompatible with a respiratory pandemic, such as those that involve spending time in closed, poorly ventilated places with many people, parties, nightlife activities. ... Raising awareness of the need to take protective measures in homes when they receive visitors, receive them in well-covered rooms, avoid family parties ... as it is in homes where the greatest number of infections occurs.

Dr. Vicente Soriano is the director of the UNIR Medical Center in Madrid and a clinician and professor of infectious diseases at the UNIR Health Sciences School and Medical Center.

MarketWatch: What do you think of Madrids new measures to try to contain the virus?

Soriano: The confluence of crowding, the return to working activities for many, and easier access to testing as compared with negligible in March largely accounts for the new surge in cases. It will go up for the next couple of weeks. Despite, to date, that many new PCR+ diagnoses have been found in young and asymptomatic people, this second wave will soon expand to the whole population, including again the most vulnerable populations. Indeed, although so far the situation at most large Madrid hospitals has not collapsed, it reminds us slightly of what happened in February, when overwhelming began to occur.

MarketWatch: What about contact tracing and other efforts?

Soriano: The advent of rapid antigen tests will be helpful, although there is room for further improvement, testing saliva (instead of nasopharynx fluid), selling in pharmacies, and allowing for self-testing at home, like pregnancy tests, as many times as convenient.

MarketWatch: What else needs to be done?

Soriano: Regional governments need to work further on three areas: (1.) increase the role of primary-care physicians as a first barrier to assess nonseriously ill patients and manage them with the help of telemedicine, avoiding the collapse of hospital emergency departments; (2.) medicalization and ensure enough health-care workers and protective equipment for nursing homes for the elderly and other institutionalized patients these places accounted for more than 60% of the death toll during the first COVID-19 tsunami wave in Spain; (3.) ensure stocks of diagnostic tests, protective equipment and enough doctors and nurses in clinics and hospitals for confronting the new COVID-19 surge. Acting upfront is always preferable to at the time of demand, when damage has already occurred.

MarketWatch: As a parent, how do you feel about sending your own children back to school?

Soriano: Reopening schools is a critical decision that is supported by the fact that youngsters very rarely become sick and allows parents to continue their jobs. So, I am in favor of reopening schools and therefore let my four children go to school, with the maximum guarantees they have established. I am aware that temporal closing of groups, classes and periodic cases will be reported. Inevitable. But working under this threat is preferable to paralyzing or closing the school.

Read on:Top coronavirus doctor in Spain has a message for revelers and tourists

Go here to see the original:
Spain virologists say the countrys second virus wave holds a valuable lesson for the rest of the world - MarketWatch

Read More...

Vaccination key to preventing twindemic – North Platte Telegraph

Sunday, September 13th, 2020

Pop quiz time. Youve got a cough, fever, chills and a runny nose: Is it COVID-19 or influenza?

The only symptoms that are unique to COVID and not unique to the flu is the loss of taste and the loss of smell, Otherwise youll have the same symptoms, said Jenny Lantis, infection prevention coordinator with Great Plains Health.

However, there is something that can help you and your health care provider figure out what youve got without waiting on test results: Whether or not youve gotten the influenza vaccine.

If you get vaccinated that will definitely help, because once you become sick with the symptoms, it may be easier to diagnose you, because we can say, You had the flu vaccine, so quite possibly what you have is COVID rather than flu, Lantis said. Thats probably the biggest, most important thing this year you can do is to get the (flu) vaccination.

The Centers for Disease Control and Prevention estimated that there were as many as 56 million cases of influenza during the 2019-20 flu season. While this season isnt expected to be as severe, the ongoing novel coronavirus pandemic raises concerns of a twindemic that could strain the health care system.

We are concerned with influenza and COVID overlapping, and one of those reasons being is that we dont want to overwhelm our health care facilities, Lantis said. Currently with a mild flu season, that does tax the hospital already, so with the overlapping of the two infectious diseases, that could overwhelm the health care facility.

The best way to help prevent overburdening the system? Get your flu shot, Lantis repeated.

Influenza vaccination is probably more important this year than ever because of the threat of the twindemic and that we could be facing the two emergencies at the same time, Lantis said. Getting vaccinated because influenza is already a deadly disease we want to make sure everyone is protected. Another good reason for getting vaccinated is because having the flu and COVID-19 on top of it could be deadly.

Great Plains Health family medicine practitioner Dr. Kali Rubenthaler echoed that sentiment.

As we head into flu season, its going to be complicated, Rubenthaler said. The flu and COVID-19 look very similar as far as respiratory symptoms go. Thats why getting a flu shot this year is more important than ever. While the flu vaccine does not prevent 100% of flu cases, it does lessen the severity and keep people from being hospitalized.

Lantis and infectious disease specialist Dr. Eduardo Freitas are cautiously optimistic that measures in place to prevent COVID-19 spread will help lessen the severity of flu season.

Dr. Freitas and I actually forecast that this flu season wont be as bad if everyone continues to mask and do good sanitizing and social distancing, Lantis said. Were hoping that will help decrease the amount of flu that we see in our community, as long as everybody is doing those preventative measures to help prevent infection.

Despite the measures in place that may help decrease the spread of the flu, Lantis said she and Freitas are concerned that there will be large numbers of people who will forgo the flu vaccination just because of all the concerns with truthfulness and accuracy of information, which leads to concerns of a widespread outbreak.

Due to the pandemic, the hospital is exploring different options for administering the vaccine to avoid having large numbers of people in one clinic.

Some options were looking at are drive-thru flu clinics, where you can schedule your vaccination in advance, and well have staff outside, kind of like our drive-thru mobile clinics for COVID, Lantis said. Were looking at options where we dont have to bring all these people into clinics just for a vaccine.

GPH has also started administering the flu vaccine to patients, and encourages people to get the vaccine as soon as it is available. According to the CDC, manufacturers have projected that they will provide as many as 198 million doses of flu vaccine, which tops the 175 million dose record set during the previous flu season.

As of Friday, 47.6 million doses of the flu vaccine have been administered.

The vaccine is not perfect, but its still a good vaccine, Lantis said. Its important to get it so you can lessen the severity of your symptoms, which will also help in decreasing hospitalizations, so that were not overwhelmed here with as many flu patients, and we can make sure we can take care of our COVID patients.

Here is the original post:
Vaccination key to preventing twindemic - North Platte Telegraph

Read More...

When You Can’t Trust The CDC: Red And Blue States Alike Flee Trump COVID Response – TPM

Sunday, September 13th, 2020

States, cities, and pharmaceutical companies are contradicting or ignoring the Trump administration in responding to COVID-19 as the White House continues to push for responses that could help the President politically while undermining the countrys ability to fight the pandemic.

The Trump administration has issued directives and statements in recent weeks that appear aimed at boosting the Presidents chances of re-election, be it predictions of a vaccine in time for Nov. 3, or a change in CDC guidance that, if followed, would reduce the volume tests, resulting in the appearance of fewer cases.

But the administrations ongoing battle against the political impact of COVID-19 rather than the disease itself has lowered confidence in the countrys public health agencies. The loss of influence has meant that states and local governments are far warier of federal public health advice.

Recent events had really shaken the confidence of health experts and the public alike,Dr. Howard Koh, a former assistant secretary for health at the Department of Health and Human Services, told TPM.

If people dont have trust and confidence in the vaccine and the FDA approval process, and in guidance from the CDC, Koh added, this pandemic will go on indefinitely.

The result is a situation in which the Trump administration issues politically motivated pronouncements that damage the federal governments ability to fight COVID-19, but which are sometimes so absurd on their face that institutions outside of the Presidents chain-of-command wont participate.

The political leadership has not been strong and it has tarnished the reputations of both the FDA and the CDC, Dr. Bill Schaffner, professor of preventative medicine and infectious diseases at Vanderbilt University Medical Center, told TPM.

The two agencies established to protect the health of the United States population have had their reputations injured, and they have been frequently sidelined by the national political mechanism, he continued. Thats painfully sad, and it will take many years for both of these agencies to restore their credibility.

TPM could identify virtually no body that took the CDCs recommendation to stop testing those exposed to COVID-19 but who displayed no symptoms. Rather, an array of states and localities across the political landscape said publicly that they would continue to test.

At the same time, President Trumps attempt to release a COVID-19 vaccine caused even the pharmaceutical firms developing the inoculation to issue an unprecedented statement affirming that they were committed to making sure that a vaccine was safe and effective before asking the government for approval.

The CDCs recommendation on asymptomatic testing last month came as a shock to many, and provoked an outcry from the public health community that caused the administration to waffle on what exactly the recommendation meant.

Experts voiced their concern that the recommendation would confuse local officials, leading them to reduce testing. But instead, states and localities decided to ignore the CDC.

Texas and Florida declined to change their guidance, and continue to recommend that those exposed to COVID-19 but who show no symptoms get tested.

North Dakotas Division of Disease Control Chief Kirby Kruger said that the state hasnt changed any of our recommendations here in North Dakota and were unlikely to because we believe our recommendations make sound public health sense.

And in Mississippi, State Health Officer Thomas Dobbs described the guidance as outdated and poorly communicated before saying that the state would not change its recommendations.

HHS spokesman Michael Caputo did not reply to a request for comment from TPM regarding examples of states or localities that had taken the CDCs recommendation.

President Trump has repeatedly promised a vaccine by Election Day, and publicly pressured the FDA to approve a vaccine by that time.

That flies in the face of timelines needed for the current vaccine trials to determine safety and efficacy. One government official told CNN that he did not know any scientist involved in this effort who thinks we will be getting shots into arms any time before Election Day.

Officials from multiple states have told TPM that they would refuse to distribute a vaccine that received federal approval without completing the necessary trials, or without receiving approval from an independent board of scientists.

Theres a process for vaccine approval thats been followed for years, and people perceiving that there were shortcuts this time is going to be disastrous, Koh said. It just cannot happen.

The seven pharmaceutical firms involved in developing COVID-19 vaccines issued a joint pledge on Tuesday morning, saying that the firms would only ask for FDA approval following convincing data showing that a vaccine candidate is safe and effective.

Dr. Schaffner, who also serves as a member of the CDCs Advisory Committee on Immunization Practices, told TPM that the statement is impressive and unprecedented.

But, Schaffner added, it falls short of specifying what the firms would do to ensure safety.

Theyre not saying they are committed to running the trial until its completion, Schaffner said. They are not saying that they insist on the FDA taking whatever decision they make and bringing it to the advisory committee that the FDA already has.

See the rest here:
When You Can't Trust The CDC: Red And Blue States Alike Flee Trump COVID Response - TPM

Read More...

Flu vaccine vital as COVID-19 deaths rise and America tries to avoid dueling winter crises – NBC News

Sunday, September 13th, 2020

As many as 34 million people sick from a respiratory virus. 490,000 hospitalizations. 34,000 deaths.

Are we talking about the coronavirus?

Nope. Just the flu. And its lurking just around the corner. In the United States, influenza (aka the flu) season typically starts in September or October and peaks between December and February, although viral activity can begin as early as September and as late as May, according to the U.S. Centers for Disease Control and Prevention. And its on a collision course with the worst infectious disease outbreak weve experienced since the 1918 pandemic.

As bad as this all sounds, in a matter of a few weeks, life as we know it will become drastically worse if we dont act now.

For the past seven months, the attention of the world has been monopolized by COVID-19. It is now the beginning of September and the novel coronavirus has infected over 27 million and killed over 832,000 worldwide at the time of publishing. The U.S. close to five percent of the worlds population comprises nearly one-quarter of all cases and deaths: surpassing 6 million and 190,000, respectively.

New cases and deaths are increasing in multiple states nationwide, as well as in Puerto Rico. The ripple effects of this health crisis have been unprecedented: record high unemployment; widespread school and university closures; staggering food and housing insecurity; escalating depression and other mental health issues; and unrelenting fatigue and burnout among front-line health care workers.

As bad as this all sounds, in a matter of a few weeks, life as we know it will become drastically worse if we dont act now. This means focusing on stopping the spread of the coronavirus while also using all of our preventative measures to prevent the spread of other respiratory illnesses such as pertussis and RSV (respiratory syncical virus), in addition to influenza. The combination of COVID-19, influenza and a panoply of acute and chronic illnesses such as heart attacks, strokes, cancer and accidents may, and likely will, paralyze our existing health care system.

Get the think newsletter.

The flu comes every year, but that doesnt make it any less deadly. The CDC estimates that over five consecutive fall-winter seasons, from 2014-2015 to 2018-2019, influenza was associated with nearly 207,000 deaths of which, 81 percent were among people ages 65 and older. The widely publicized 1918 influenza pandemic was associated with 675,000 deaths in the U.S. and 50 million worldwide.

Like COVID-19, influenza can also cause a whole host of nasty complications. While most people who get influenza will recover in less than two weeks, others can experience life-threatening conditions such as pneumonia, myocarditis, encephalitis and multi-organ failure.

Also like COVID-19, the flu disproportionately impacts racial/ethnic communities. Between 1929 and 1931, the influenza mortality rate per 100,000 was 30.3 among whites and 71.3 among nonwhites. By 1950, the influenza and pneumonia mortality rates were 44.8 and 76.7, respectively.

But unlike COVID-19, which seems to have mostly milder effects on children, healthy kids are at higher risk of complications for influenza, according to the CDC. (However, infants and children with underlying conditions are at increased risk for both viral infections.)

Unfortunately, influenza and COVID-19 are not the only respiratory viral infections that will tax our health care system and use competing resources such as point-of-care testing, hospital beds, ventilators and supportive medications. Many other viruses cause infections deep in the chest. Layered atop widespread COVID-19, these infectious pathogens will likely wreak havoc on an already overburdened health care system.

In addition, the fall and winter of 2020 will bring us another complicated seasonal respiratory infection: enterovirus D68. Although rarely seen in the U.S. prior to 2014, weve been seeing this infection circulate over the past several years. The good news? It usually causes a mild to moderate respiratory infection in children. The bad news is that enterovirus D68 can lead to acute flaccid myelitis, a rare but serious neurologic condition that can evolve over hours to days. Health officials are concerned that parents may hesitate to take their children for evaluation and treatment of mild neurologic symptoms out of concern for COVID-19 infection risk.

Lets focus on the infections we can mitigate at this point. The good news with influenza? Unlike with COVID-19, we have:

Rapid testing that, while not sensitive, remains a helpful specific tool. There are also multiple available and safe treatments. Four FDA-approved antiviral drugs have been approved just this year: oseltamivir (Tamiflu), zanamivir (Relenza), peramivir (Rapivab) and baloxavir (Xofluza). There are also multiple FDA-licensed vaccines produced each year, not to mention the decades of information that scientists are always consulting to make sure we have data to track flu mutations and adjust treatment and prevention methods.

Despite the availability of a flu vaccine, at best an estimated 40 to 50 percent of the population opts for this preventive measure. But now more than ever, the medical community is united in its support of this vaccine.

As with the coronavirus pandemic, we will need strong leadership from our elected officials including massive funding of public health agencies, consistent messaging rooted in science and targeted outreach to our most vulnerable communities in order to avoid a tsunami of medical crises this fall and winter.

Is it possible that current mitigation efforts against COVID-19 will reduce the anticipated burden of influenza infections? Yes, and that would be a welcome outcome to all health professionals, especially those working on the front lines. So lets do everything we can to soften the blow of COVID-19 and the flu.

Related:

Dr.LipiRoy is aninternal medicine physician and NYUfaculty member. She has provided medical relief to earthquake victims in Haiti and is currently the medical director at Housing Works, overseeing medical services at COVID-19 isolation and quarantine sites in New York. She is also an MSNBC and NBC News medical contributor.

Dr. L. Brett Jaggers

Dr. L. Brett Jaggers is an infectious disease expert who has specialized in respiratory viruses and pandemic response. She was co-director for the Duke University Health System response to the Influenza H1N1 emergence in 2009. She currently treats patients in Denver, Colorado.

Here is the original post:
Flu vaccine vital as COVID-19 deaths rise and America tries to avoid dueling winter crises - NBC News

Read More...

Dane County, UW prepared to handle influx of COVID-19 cases on campus – UW Badger Herald

Sunday, September 13th, 2020

Dane County officials said the University of Wisconsin and Dane County have proper policies in place to keep COVID-19 under control on campus this fall.

This May, Public Health Madison and Dane County released the Forward Dane plan, which set standards for workplaces, schools and recreational facilities as the county began to reopen. In June, Dane County entered phase two of the Forward Dane plan, which allows post-secondary education institutions to operate as usual, no longer restricted to distance learning as they were in phase one.

Despite the growing list of universities across the country whose reopening plans have failed due to spikes in COVID-19, students moved into dorms in late August and many registered for in-person classes.

UPDATED: Teaching assistants march to UW Chancellors house, challenge safety of fall semester restart planThe Teaching Assistants Association protested in-person classes Saturday in a march to the official residence of the University of Wisconsin Read

Communications Director for Public Health Madison & Dane County, Sarah Mattes, said student behavior is key in Dane Countys success as a community in preventing an increase in cases.

The driver of disease transmission isnt happening in the classroom it is happening as students socialize, Mattes said.

The University of North Carolina at Chapel Hill became a national example of student socializing gone wrong when COVID-19 clusters appeared in three residence halls and a fraternity house within the first week of the fall term, according to the Washington Post. A video surfaced on Twitter of a group of UNC students who did not socially distance or wear masks at an off-campus sorority party, according to CBS 17.

Chapel Hill police also reported an increase in 911 calls concerning large crowds not practicing social distancing. In response, UNC announced students who violate state or local ordinances or do not comply with standards relating to COVID-19 will be subject to disciplinary action through the Student Affairs Office, according to the Daily Tar Heel.

UPDATED: UW System releases official COVID-19 guidelines for the fall semesterThe University of Wisconsin System released official guidelines Sunday for universities to safely reopen their campuses this fall during the Read

UW spokesperson Meredith McGlone said UW will follow the Dane County Public Health Order which outlaws indoor gatherings of more than 10 people.

McGlone also said UW fraternities and sororities pledged all events will follow county public health guidelines and have prohibited social gatherings which include alcohol.

UW freshman Rachel Dimeo said she is doubtful these policies will be followed.

If dorms could actually social distance and wear masks, I do not think COVID would be a rapid problem, but I know this is not the case, Dimeo said. I have seen many people congregating together without masks and are crammed into little dorm rooms and even parties.

Man breaks into Langdon Street Fraternity, uses samurai sword to cause damage, open doorsWednesday, a man broke into the Delta Chi fraternity house on the 100 block of Langdon Street, going through several Read

Apress release from UW explained classes this fall would offer in-person instruction in many courses until the Thanksgiving recess, after which they will switch to a virtual format for all courses for the final nine days of instruction plus exams.

The Smart Restart plan describes UWs three-part testing plan, which includes unlimited free drop-in tests, surveillance testing to track the prevalence of the virus on campus and target testing for all students and staff living in residence halls. Additionally, everyone on campus will be required to wear a face covering, practice social distancing and self monitor for symptoms.

Hundreds of colleges across the country reversed or remedied their reopening plans, including many Big Ten universities. Michigan State closed undergraduate residence halls and moved classes online, according to Inside Higher Ed, and theUniversity of Minnesotas governing board voted to delay the opening of dormitories and the start of in-person undergraduate classes by at least two weeks, according to the Star Tribune.

As a premier residential university, we believe deeply in the value of face-to-face instruction, McGlone said. We believe students want to be in Madison to learn in person and that they will rise to this opportunity for in-person learning. Having students on campus and providing in-person instruction, where feasible, provides a better set of educational opportunities for students lacking suitable technology or spaces to effectively study at home.

Families, off-campus students deal with financial impact of COVID-19Mayor Satya Rhodes-Conway sent a request Aug. 10 to the Wisconsin Public Service Commission, which regulates public utilities in Wisconsin, Read

Not all Big Ten universities changed their reopening plans. Ohio State allowed students to return to campus and is now monitoring the virus with consistent testing, according to Ohio State News.

As of early September, the overall student positivity rate at Ohio State was 3.13%, with 882 students testing positive, according to the Columbus Dispatch. Only 165 isolation and quarantine beds remain available on campus a decrease from the 351 beds available as of late August.

UW is also using quarantine and isolation housing to keep students safe this fall, according to University Health Services Chief Preventative Medicine Resident Colin Pitts. There are approximately 700 spaces available in quarantine housing and 400 in isolation housing. There is currently no data available on the University Health Services website regarding the number of students living in quarantine and isolation housing.

If you test positive [for COVID-19] you are isolated, Pitts said. We have isolation facilities for that, where essentially, if you [test] positive, you go into this dorm for 10 days after the positive test. We send you a symptom survey to see how youre doing and housing checks in on you. If you are close contact, so 15 minutes unmasked, close together, within six feet, or if you are in the same living space, so same door room that causes close contact, we have a quarantine facility.

Students are tested twice while in quarantine, once in the early days of their stay and once near the end, Pitts said. Quarantined students are also monitored with a symptom tracker.

While students are technically able to go home as opposed to living in quarantine or isolation housing if they are exposed to the virus, Pitts said students are strongly encouraged to quarantine on campus because of access to testing within quarantine and isolation housing and because their symptoms can be monitored.

COVID-19 in College: Students recovered from COVID-19 share experiences as year beginsIn the past few months, much of the college experience has been reduced to watching. Watching Netflix, watching online lectures Read

At the University of Iowa, 500 students self-reported positive COVID-19 tests in late August. A university notice announced if the positive case rate did not flatten over the next week, the university would consider additional actions, according to Iowa City Press-Citizen.

Our plans are informed by the latest science and public health information, McGlone said. They include a robust testing regime, contact tracing, symptom monitoring, enhanced cleaning protocols, mandatory wearing of face coverings in university buildings and public spaces where physical distancing isnt possible, and physical distancing in all classrooms.

McGlone said the percentage of students testing positive, available beds in on-campus isolation and quarantine, Dane County policy, percentage of Dane County residents testing positive, the capacity of the UW health care system and the consultation of on-campus infectious disease experts are all taken into consideration.

McGlone and Mattes said no one criterion will take precedence over another in the decision-making process, and multiple contingency plans gave UW flexibility during uncertain times.

UW-Madison is a part of [Dane Countys] community, and decisions made for campus will affect the rest of our community, Mattes said. Everyone, including college campuses and other venues which bring large groups of people together, must take the necessary steps to prevent the spread of COVID-19 if we are to keep the pandemic under control.

Read the rest here:
Dane County, UW prepared to handle influx of COVID-19 cases on campus - UW Badger Herald

Read More...

Learning from the history of pandemics – East Asia Forum

Sunday, September 13th, 2020

Author: Michael Shiyung Liu, Shanghai Jiao Tong University

In 1972 microbiologists Macfarlane Burnet and David White predicted that the future of infectious diseases will be very dull. COVID-19 has been anything but.

The pandemic has mocked modern public health and medical science worldwide. The United States the society with the most advanced medicine and public health tops mortality rates. It had an epidemic policy and infrastructure in place that the Trump administration dismantled in 2018. China a country with a population of 1.43 billion saw only a slim fraction compared to the cases discovered among a US population of 330 million.

Columnists at The New York Times scoffed at Wuhans January lockdown policy, but two months later several European cities enacted similar restrictions. There is no major difference between the Wuhan lockdown and the cordon sanitaire that prevented yellow fever or cholera in 19th century Britain. In a megacity like Wuhan, modern information exchange technologies, transportation of medical resources and even the effective execution of political power all play crucial roles in stopping the spread of an unknown virus.

But rather than recognise the effectiveness of Wuhans lockdown, the column focused instead on the non-transparency of the policies, while questioning the credibility of the public health sectors in China. In the following months, the debate about the transparency of Chinas pandemic statistics further blocked mutual coordination and damaged trust between societies.

The debate on the transparency of official epidemic reporting has a long history and featured during the establishment in the 1920s of the League of Nations Health Organization, the predecessor to the World Health Organization (WHO). International coordination for pandemic prevention has weathered many obstacles since the 18th century. The accomplishment of an international health infrastructure under the WHO is therefore a centrepiece of globalisation in the 21st century.

Diseases have no political boundaries is the widely-used expression for advocating international coordination in the public health arena. Looking back in East Asia, for example, the public health risks that acquired international attention were associated with the panic of pandemics during the first half of 20th century. The inequalities between colonial societies and western powers brought obstacles to information exchange and health promotion. The competition between colonial powers and sovereign states also added to tensions between colonial medicine and the practices of international health, both of which played essential roles in shaping health governance.

But common ground for public health did exist in East Asia in the 1930s among three major organisations: The League of Nations Health Organization (LNHO), the Far Eastern Association of Tropical Medicine (FEATM) and the International Health Division (IHD) of the Rockefeller Foundation. The LNHO brought an international framework to link the health needs of the East and the West, the FETM created an unofficial network to bypass the limitations of the Westphalian system, while the IHD poured funding and medical ideas into the key institutions of international health in East Asia.

It still took four decades for the United States to harvest former efforts and put old wine in new bottles, in the form of the WHO Regional Office for the Western Pacific (WPRO). The WPRO would promote international health as a means to protect US interests and provide an agency to secure allies in the region, a mission that was written in pages of documents and correspondences among the three organisations. The Trump administrations withdrawal from the WHO makes a mockery of the historical endeavour to create a foundation for international health.

From AIDS to Ebola and SARS, now COVID-19, contagious viruses continue to threaten and disrupt. Historians, who never lost interest in pandemics, have much to offer. Learning the history of the interactions between East Asian organisations of international health illuminates a constant phenomenon: as medical technologies advance, social biases and political frictions prevent international cooperation, particularly in the exchanging of experiences with public health measures like quarantine and medical and scientific research on disease.

Charles Rosenberg argues for the importance of identifying similarities between pandemics, especially in the ways that societies inquire into the origin of an outbreak, the ways they demand urgent state intervention and the ways in which collective responsibility can be a framework for communal support. These insights should inspire societies to consider why various strategies are adopted in different contexts.

While all societies demand a political response, the response to pandemics varies from restrictive quarantine without concern for human rights to ignoring public health warnings and preventative actions. All these responses have repeatedly appeared in the past. Pandemics eventually resolve by a process, as Rosenberg put it, that starts at a moment in time, proceeds on a stage limited in space and duration, follows a plotline of increasing revelatory tension, moves to a crisis of individual and collective character, then drifts toward closure.

This drama is playing out with COVID-19 first in China and then in many countries worldwide. History can be a resource to provide inspiration and understanding for controlling pandemics under different social contexts and is just as essential as the natural sciences are for generating quarantine strategies and treatments. The end of the pandemic depends on a combination of the life cycle of the virus and earnest human efforts at vaccine development and treatment. Equally important is the social awareness to prevent human bias impeding international cooperation.

Michael Shiyung Liu is Distinguished Professor at the School of Humanities, Shanghai Jiao Tong University, and Professor at the Asian Studies Center, the University of Pittsburgh, Pennsylvania.

See the original post here:
Learning from the history of pandemics - East Asia Forum

Read More...

electroCore to Present at the HC Wainwright Virtual 22nd Annual Global Investment Conference – Yahoo Finance

Sunday, September 13th, 2020

BASKING RIDGE, N.J., Sept. 11, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc.(Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that management is scheduled to present at the HC Wainwright Virtual 22nd Annual Global Investment Conference, which is being held from September 14-16, 2020.

Presentation details:

Date: Wednesday, September 16, 2020Time: 1:30-1:50pm EDT

A live webcast of the presentation will be available on the Investors section of the company's website:www.electrocore.com

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The companys current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit:www.electrocore.com

Investors:Hans VitzthumLifeSci Advisors617-430-7578hans@lifesciadvisors.com

or

Media Contact:Jackie DorskyelectroCore973-290-0097

See the original post here:
electroCore to Present at the HC Wainwright Virtual 22nd Annual Global Investment Conference - Yahoo Finance

Read More...

The aging brain: Exploring the connection between neurology and elevation – Summit Daily News

Sunday, September 13th, 2020

ASPEN It isnt noticeable at first. It starts with changes for which the brain can compensate, meaning no real impact on day-to-day functions or cognition.

But as time passes, the brain can no longer compensate for the damage its experiencing. Subtle problems with memory and thinking begin to pop up. Subtle turns to noticeable. Noticeable turns to difficulty carrying out everyday activities. Eventually, around-the-clock care is required.

This is the broad view progression from preclinical to severe Alzheimers disease, a degenerative brain disease that becomes worse with time and age, and is the most common cause of dementia, according to the Alzheimers Association.

In Colorado, an estimated 76,000 people are living with Alzheimers dementia, and that number is expected to increase 21% to 92,000 by 2025, a 2020 Alzheimers Association report states. As of July 2019, 14.6% of Coloradans, or about 840,000 people, were 65 or older, U.S. Census Bureau data shows.

While its been shown that living in higher elevation communities can lead to a more active, healthier lifestyle and even prolonged life, its less clear how living at high elevation correlates with degenerative brain diseases.

In short, the answer is complicated and not well researched.

As far as I know, there isnt a lot of evidence one way or another about high altitudes versus low altitudes for Alzheimers disease risk, said Dr. Huntington Potter, director of the Alzheimers and Cognition Center at the University of Colorado Anschutz Medical Campus. We cant say one way or another whether high altitude is a risk factor for Alzheimers.

At the Alzheimers and Cognition Center, which is part of the CU Anschutz Medical Campus and School of Medicine, clinicians and researchers are dedicated to discovering effective early diagnostics, preventions, treatments and ultimately cures for Alzheimers disease and related neurodegenerative disorders, according to its website.

For Potter, that means looking at biomarkers or diagnostic proteins in the blood that can help clinicians predict the disease earlier, conducting projects that look at the lifespan of people with Alzheimers disease, and other research that can quickly be translated to better care, treatment and hopefully a cure.

Right now, the center is studying a drug called Leukine, which preliminary data shows might improve Alzheimers disease in the short term, Potter explained. The center also is studying other drugs that attack the disease.

Leukine may be the first one we found that looks promising, but we have several coming up that look promising, as well, Potter said.

When it comes to looking at the potential correlation between living at high elevation and the risk for dementia-inducing diseases, Potter and Dr. Peter Pressman of the Alzheimers and Cognition Center said it would take great effort, time and funding to research.

Assistant professor for the Department of Neurology, Dr. Peter S. Pressman works in his office at the University of Colorados Anschutz Medical Campus in Aurora on Thursday, Sept. 10. Photo by Liz Copan / Studio Copan

Assistant professor for the Department of Neurology, Dr. Peter S. Pressman is pictured outside his office building at the University of Colorados Anschutz Medical Campus in Aurora on Thursday, Sept. 10.Photo by Liz Copan / Studio Copan

Assistant professor for the Department of Neurology, Dr. Peter S. Pressman works in his office at the University of Colorados Anschutz Medical Campus in Aurora on Thursday, Sept. 10. Photo by Liz Copan / Studio Copan

Assistant professor for the Department of Neurology, Dr. Peter S. Pressman works in his office at the University of Colorados Anschutz Medical Campus in Aurora on Thursday, Sept. 10. Photo by Liz Copan / Studio Copan

Show CaptionsHide Captions

Pressman, who is a behavioral neurologist and researcher with the center, said on top of securing and carefully selecting a large group of people living at elevation to participate in a study, researchers also would have to follow that group for about a decade to get meaningful results.

Its easy to fund a study for a few years, Pressman said. People give you money to do something for two to three years, but two to three years is not enough time for a process as slow as Alzheimers and dementia to really even pick up. Im not saying thats not possible. Its doable, but it would take some effort.

Dr. Brooke Allen, neurologist, founder of Roaring Fork Neurology in Basalt and medical director at Renew Roaring Fork, an assisted living and memory care center in Glenwood Springs, expressed similar thoughts.

As a part of any mild cognitive impairment or dementia evaluation, Allen said her team checks the oxygen level a patient has and considers the elevation at which that person spends most of their time.

Lower oxygen levels can contribute to people experiencing confusion, dizziness and mild short-term memory issues. But outside of looking at oxygen levels and how they could be contributing to symptoms, Allen said she doesnt consider elevation a higher risk situation.

Allen said she feels High Country residents 65 and older tend to be much younger than their age in terms of their lifestyle, which is a positive in terms of dementia prevention.

About four years ago, Allen and her team conducted a long-term preclinical Alzheimers trial as part of the Alzheimers Prevention Initiatives Generation Program, a study that looked at the effectiveness of preventative treatments for individuals between 65 and 75 who had no symptoms of dementia.

Allen said more than 250 people came in to participate in the study and all generally led healthy, active lifestyles.

I think in our valley, Ive experienced meeting those kinds of people and not thinking of altitude as a risk factor but as a lifestyle opportunity in a rural area like ours, Allen said about the people who participated in the study.

Looking at the potential correlation between living at high elevation and risk of degenerative brain diseases is not just a difficult feat for Colorado researchers. Little research with concrete findings exists nationally or globally.

One study published in 2015 by Dr. Stephen Thielke in JAMA Psychiatry looked at deaths attributed to Alzheimers dementia reported in 58 counties in California to try to determine whether rates of dementia were associated with average elevation of residence. The study found that the counties at higher elevation generally had lower rates of dementia mortality.

Additional work is needed to determine whether this relationship holds in other populations, the study notes.

But beyond this study, there isnt much conclusive evidence for or against a correlation, as emphasized by Dr. Brent Kious, a psychiatrist, assistant professor and researcher with University of Utah Health and the schools Department of Psychiatry.

Kious has studied the link between living at high elevations and major depressive disorder, anxiety and suicide, and he said he and his research team have been interested in the impact of elevation on the incidence and median age of onset of Parkinsons disease.

However, Kious said decrements in cognitive performance due to chronic exposure to moderately high elevation might not necessarily translate into an increased risk of dementia.

It is not clear whether altitude would affect those neurodegenerative processes or not, though there is some reason to think that they involve oxidative damage so relative hypoxia might slow them, Kious wrote in an email. He went on to note that relative and prolonged hypoxia, or a lack of oxygen, has been associated with dementia risk. In any case, a good epidemiological study of the association between altitude and dementia should control for things that might be associated with both.

Karen Eck, 60, of Silverthorne, picks tomatoes at the Timberline Adult Day Program garden in Frisco on Thursday, Sept. 10. Eck, who was diagnosed with early onset Alzheimers, attends programs three to four times a week at the center.Photo by Jason Connolly / Jason Connolly Photography

Karen Eck, 60, of Silverthorne, waters tomatoes at the Timberline Adult Day Program garden in Frisco on Thursday, Sept. 10. Eck, who was diagnosed with early onset Alzheimers, attends programs three to four times a week at the center.Photo by Jason Connolly / Jason Connolly Photography

Karen Eck, 60, of Silverthorne, poses for a portrait at the Timberline Adult Day Program garden in Frisco on Thursday, Sept. 10. Eck, who was diagnosed with early onset Alzheimers, attends programs three to four times a week at the center.Photo by Jason Connolly / Jason Connolly Photography

Karen Eck, 60, of Silverthorne, enters the Timberline Adult Day Program in Frisco on Thursday, Sept. 10. Eck has early onset Alzheimers.Photo by Jason Connolly / Jason Connolly Photography

Karen Eck, 60, of Silverthorne, leaves the Timberline Adult Day Program garden in Frisco after watering tomatoes on Thursday, Sept. 10. Jason ConnollyPhoto by Jason Connolly / Jason Connolly Photography

Show CaptionsHide Captions

While theres not good data for or against high elevation as a risk factor for degenerative brain diseases, there is evidence that people living in more rural communities do not have the same access to dementia care and treatment as those living in urban areas.

According to the 2020 Snapshot of Rural Health in Colorado, produced by the Colorado Rural Health Center, 721,500 people are living in rural Colorado and 19% of the rural population is age 65 or older. Rural is defined as a nonmetropolitan county with no cities over 50,000 residents.

Chad Federwitz a gerontologist, or specialist in the study of aging, and manager of Pitkin County senior services said he hasnt seen any correlation between living at high elevation and dementia risk. Anecdotally, he does know that people move to Grand Junction or the Front Range if they have dementia because of a lack of care resources in the High Country.

Given the nature of our rural-ish community, we dont have the same resources, Federwitz said, referring to things like long-term assisted living and memory care options. You can go to Grand Junction or the Front Range and have pages and pages of resources as opposed to here.

While there are some dementia care resources in more rural Colorado communities, the Alzheimers and Cognition Center is working to do more to develop meaningful relationships with health care providers and dementia patients in the states mountain communities as part of its mission.

According to Pressman, who is heading this charge on behalf of the CU center, a lot of projects are in the planning stages but include virtually educating medical providers, nurse practitioners and primary care doctors on Alzheimers and general healthy brain aging as well as mutual, participatory research with rural Colorado communities and communities of color.

Pressman explained that a lot of research related to Alzheimers overwhelmingly is based on middle-class, well-educated, white participants. And so while researchers think they know a lot about the disease in general, they really only know about the disease related to this demographic group.

Through the centers outreach and efforts to better connect with underrepresented communities, Pressman hopes to conduct better science and better serve the larger Colorado community.

What motivates me is trying to do good work, trying to do good science and to make sure our results actually represent real life, Pressman said. We want to make sure were helping everybody, not just a niche group, and that our services are available equitably to as many people as possible.

Editors note: This is Part 2 of a four-part series on longevity in the High Country. The series is being produced in partnership with The Aspen Times, Glenwood Springs Post Independent, Steamboat Pilot & Today and Vail Daily. Read more at SummitDaily.com/longevity.

See the original post:
The aging brain: Exploring the connection between neurology and elevation - Summit Daily News

Read More...

We’ve known for over a century that our environment shapes our health, so why are we still blaming unhealthy lifestyles? – The Conversation UK

Sunday, September 13th, 2020

Were healthier and live longer than our ancestors, yet were constantly reminded of deaths caused by war, terrorism and natural disasters. As terrible as these events are, they accounted for less than 1% of the 56 million worldwide deaths in 2017.

Another colossal distraction is the focus on lifestyle as a way to better peoples health and reduce health inequalities. Of course, what people eat, how much they exercise, whether they smoke and how much alcohol they drink have a bearing on their health. But what matters much more is the circumstances in which people are born, live, work and age the social determinants of health.

The fact that the environment shapes peoples lives and health has been known for a long time. In 1842, Edwin Chadwicks Report on the Sanitary Condition of the Labouring Population of Great Britain highlighted how the ill health of the poor was not the result of their idleness but of their terrible living conditions.

In his semi-autobiographical novel The Ragged Trousered Philanthropists, written over a century ago, Robert Tressell explained how the poor health of the hero of the book, impoverished painter and decorator Frank Owen, could not be solved by medicine alone. It was social medicine that he needed:

The medicine they prescribed [Frank Owen] and which he had to buy did him no good, for the truth was that it was not medicine that he like thousands of others needed, but proper conditions of life and proper food.

And over 70 years ago, Sir William Beveridge, the architect of the British welfare state, called for action to tackle the root causes of poor health: poverty, low education, unemployment, poor housing and other public health issues, such as malnutrition and inadequate healthcare.

There is no denying that great progress has been made since the work of Chadwick, Tressell and Beveridge. Far fewer people in the UK experience the absolute poverty, squalor and overcrowding they described.

But the fact remains: the profound health inequalities between rich and poor that have been highlighted throughout the past century most notably in the Black Report, which was published 40 years ago remain today. In 2020, a baby boy born in wealthy Kensington, London, can expect to live over ten years longer and nearly 20 more years in good health than a baby boy born in relatively deprived Kensington, Liverpool.

Today, a proportion of children still live in absolute poverty. They lack sufficient nutritious food and their families rely on food charity. They dont have a stable, decent home and are exposed to damp, excess cold, and dangerous levels of carbon monoxide. The proportion of people sleeping rough is also rising.

Beveridge saw employment as the solution to poverty, yet the number of people in in-work poverty is close to 4 million, and a growing number of jobs are part time, low paid or temporary.

The solution to poor health is to prevent it from happening in the first place. But rather than taking a preventative approach and fostering healthy lives through bettering the environments and conditions in which people live, national health services, such as the UKs NHS, are primarily set up to treat the symptoms of poor health.

Essentially, the UK has a National Disease Service. Its an incredibly good one, but the primary drive should be to prevent these expensive-to-treat chronic health conditions arising in the first place. Unfortunately, the big loss in public-health grant funding for local councils in the UK in recent years is testament to the governments continued focus on treatment.

The public health education campaigns that do exist encourage people to move more, eat healthier and limit alcohol consumption. They disregard underlying economic factors and neglect the fact that many people simply dont have the same opportunities or resources to be as healthy as others do.

The economic basis of poor health is all too relevant today given the increasing return of diseases of poverty and the emergence of devastating new epidemics such as COVID-19.

The reality is that peoples health choices are heavily influenced by the conditions in which they live. Whether they have a job thats safe, secure and decently paid, and one that gives them control, flexibility and meaning. Whether theyre able to afford a well-heated, well-lit, stable home in a safe area. Whether they have the money, time and resources to buy and cook healthy food and have an active lifestyle. Whether they have a walkable community that provides access to green space and essential services.

Lifestyle is also important for health, but lifestyle behaviours have causes and these causes have causes, too. Its these wider determinants of health that affect our health most.

That the most deprived areas experience almost ten times as many child pedestrian fatalities than the least deprived areas is a fitting example of how still to this day where you live can kill you.

Visit link:
We've known for over a century that our environment shapes our health, so why are we still blaming unhealthy lifestyles? - The Conversation UK

Read More...

Wearing a mask could reduce COVID-19 severity, researchers say | TheHill – The Hill

Sunday, September 13th, 2020

Masks have become commonplace for most Americans venturing out in public as the coronavirus pandemic has dragged on for several months.

Face coverings have proven to be a key preventative measure for slowing the transmission of COVID-19 as the world waits for a safe and effective vaccine.

Our country is in a historic fight. Add Changing America to yourFacebookorTwitterfeed to stay on top of the news.

But a new paper argues there may be an additional benefit.

Monica Gandhi and George Rutherford from the University of California, San Francisco theorize in commentary published in The New England Journal of Medicine that mask-wearing could also significantly reduce the severity of the disease in those who become infected and ensure a greater number of infections are asymptomatic.

Studies show masks do not filter all airborne droplets, and its still possible for the virus to sneak through and infect the wearer.

But the ideabehind the theory is that masks can block a significant number of coronavirus droplets, lowering the dose of the virus a person inhales and reducing the chances the person will experience serious illness.

An immune response could also potentially be triggered in the mask-wearer with a small amount of virus.

SARS-CoV-2 has the protean ability to cause myriad clinical manifestations, ranging from a complete lack of symptoms to pneumonia, acute respiratory distress syndrome, and death. Recent virologic, epidemiologic, and ecologic data have led to the hypothesis that facial masking may also reduce the severity of disease among people who do become infected, the paper said.

If this hypothesis is borne out, universal masking could become a form of variolation that would generate immunity and thereby slow the spread of the virus in the United States and elsewhere, as we await a vaccine, researchers wrote.

Researchers cited several examples of masks leading to less severe outcomes in infections.

A study involving hamsters showed those living in mask-shrouded cages were less likely to be infected and showed fewer symptoms compared with unmasked hamsters, researchers said.

An outbreak on a closed Argentinian cruise ship where passengers were provided with surgical masks and staff with N95 masks resulted in 81 percent of infected passengers never developing symptoms. Thats compared to the coronavirus outbreak on the Diamond Princess cruise ship outside of China where only 18 percent of the passengers infected were asymptomatic.

During two outbreaks at U.S. food-processing plants where all workers were issued masks each day and were required to wear them, 95 percent of those who tested positive were asymptomatic while 5 percent experienced mild symptoms, the researchers noted.

Researchers noted further studies comparing the rate of asymptomatic infection in areas with and without universal mask-wearing are needed.

WHAT YOU NEED TO KNOW ABOUT CORONAVIRUS RIGHT NOW

FAUCI PUSHES BACK AGAINST MINIMIZING OF CORONAVIRUS DEATH TOLL

HERD IMMUNITY EXPLAINED

THE PROBLEM WITH HOLDING UP SWEDEN AS AN EXAMPLE FOR CORONAVIRUS RESPONSE

FALSE POSITIVE AND NEGATIVE TEST RESULTS EXPLAINED

CAN LYSOL OR CLOROX KILL THE CORONAVIRUS?

THESE ARE THE 6 WAYS THE CORONAVIRUS PANDEMIC COULD END

View original post here:
Wearing a mask could reduce COVID-19 severity, researchers say | TheHill - The Hill

Read More...

Boston to randomly test teachers and other educators weekly for COVID-19 – msnNOW

Sunday, September 13th, 2020

David L. Ryan/Globe Staff At the Mather Elementary School in Dorchester, letters A and B on desks are for students to alternate on separate days during the week to keep a social distance.

Boston officials and the teachers union unveiled plans on Thursday to randomly test teachers and other educators on a weekly basis for COVID-19, making the citys school system one of the first in the state to commit to routine testing.

Under the plan, the district will test up to 5 percent of the members of the Boston Teachers Union on a weekly basis, giving high priority to those working in schools in neighborhoods with high COVID-19 positivity rates as well as employees who work directly with students where social distancing is not possible, such as those providing hands-on support for some students with profound disabilities.

The move part of a broader agreement with the Boston Teachers Union on reopening schools that was announced Thursday comes as the city has been grappling with wide variations in coronavirus cases among its neighborhoods. Of particular concern is East Boston, which has the highest weekly positivity rate, 8.7 percent.

If East Boston were its own school system, state guidelines would strongly recommend keeping classrooms closed because its positivity rate is so high. However, Bostons overall weekly positivity rate is 1.7 percent, according to the most recent city data, enabling the districts classrooms to reopen.

Boston will begin online classes citywide on Sept. 21 and then gradually bring students back into classrooms in waves, starting in October with the highest-need students, including those with profound disabilities and those who do not know English.

Mayor Martin J. Walsh announced the union agreement as part of his routine briefings on the citys virus efforts. He highlighted the provision about the routine COVID-19 testing of union employees and other measures in the agreement such as additional training for educators on how to teach remotely and the ability to bring their own children to school if they cant secure child care.

The focus of this framework is ensuring the safety of everyone in our schools, Walsh said.

Jessica Tang, president of the Boston Teachers Union, described the testing program as a good first step, but said she would like to see more wide-scale testing of staff. She noted educators report to their schools from across the city and the region while students also criss-cross the city to get to their schools many relying on public transit creating ripe conditions for a widespread outbreak.

If we are focusing efforts on places with highest risk of infection, hopefully it will help prevent or limit spread, Tang said.

She said she would like the district to administer rapid testing for educators exhibiting symptoms to determine whether they have been infected or are instead suffering from the flu, allergies, or something else. Tang said the move would decrease potentially unnecessary quarantines that would keep teachers away from their students.

Boston appears to be one of just a handful of districts in the state that is planning to test teachers.

Cambridges school committee made routine testing for teachers a condition of reopening school buildings for students next month. The city is finalizing plans with the Cambridge-based Broad Institute to offer a testing program for all staff who will work in school buildings, said Lyndsay P. Brown, chief strategy officer for Cambridge Public Schools. The plan will not have to be approved by the school committee, said Brown.

Wellesley and Hanover plan to test staff before they enter schools, according to union agreements with the districts. Wellesley will also provide free testing once a week for staff for preventative monitoring. Watertown, Everett, Revere, and Lexington are also planning to offer at least some testing to school staff, according to the Massachusetts Teachers Association.

Debate over whether to routinely test educators has been unfolding over the summer as districts prepare to reopen schools. It intensified after Governor Charlie Baker announced plans to dispatch mobile COVID-19 testing units to schools experiencing potential clusters of cases. Teachers unions criticized the move as too reactive as they pressed for wide-scale free testing of teachers and students as a preventative measure.

The Massachusetts Department of Elementary and Secondary Education, however, has not issued any guidelines on routine testing, while the Centers for Disease Control and Prevention doesnt recommend universal testing for asymptomatic school employees and students.

In its guidance, the CDC said it is not known if testing in school settings provides any additional reduction in person-to-person transmission of the virus beyond what would be expected with implementation of other infection preventive measures, such as social distancing, mask wearing, hand washing, and enhanced cleaning procedures.

The guidance also says universal testing could present some challenges, including whether all students, parents, and staff would be receptive to the idea.

But Joshua Barocas, an infectious disease physician at Boston Medical Center and a faculty member at Boston University School of Medicine, said there can be value in doing sample testing if it is part of a broader COVID-19 prevention plan. He compared it to the kind of surveillance and population testing occurring in nursing homes, shelters, and other congregate settings, which aim to test between 20 to 40 percent of people every two or four weeks.

It can be effective at recognizing an outbreak early, said Barocas, but it also can lead to the need for further investigation and testing. Im hopeful if someone sees a possible signal of an outbreak . . . that they would increase testing to determine if its actually a signal or just noise.

He said going with a sampling of 5 percent of union members each week is a good starting point and from there the district could assess whether its large enough to be effective in either spotting potential outbreaks or instilling confidence among educators, students, and parents that they will be safe.

At 5 percent, the testing program is a potentially ambitious effort for the BPS, and could mean testing up to approximately 375 educators a week or 1,500 over the course of a month, according to Globe calculations. The Boston Teachers Union has about 7,500 active members, including nurses, classroom aides, and guidance counselors across 125 buildings.

But not all union members would be eligible for testing. The agreement limits testing to only those who report to school buildings with students inside. Members can only be tested every 14 days. Results would be available within 24 to 48 hours.

The district will provide weekly public reports on incidents of infection by school, according to the agreement.

Many details of the testing program are still being worked out with the Boston Public Health Commission, a school spokesman said Thursday night. The school system also had no estimated cost for the program and did not say where the money would come from to cover the testing.

Thomas Scott, executive director for the Massachusetts Association of School Superintendents, said he has mixed feelings about routine testing, especially the cost and the possibility of false positives for employees with no symptoms.

Having regular testing probably has some value," he said, but he added, "I dont know if it will make a difference for districts in preventing transmissions.

Beth Kontos, president of the American Federation of Teachers Massachusetts, which Boston teachers belong to, said she views the BPS COVID-19 testing as a win for public health. But she wishes the state would create a routine testing program for all districts instead of just providing emergency testing.

Its a shame we have to wait for people to get sick until we do the right thing, she said.

Felicia Gans and Naomi Martin of the Globe staff contributed to this report.

See the rest here:
Boston to randomly test teachers and other educators weekly for COVID-19 - msnNOW

Read More...

Lars Andersson, PhD: The Future of Personalized Medicine for Asthma – MD Magazine

Sunday, September 13th, 2020

Despite not being able to attend conferences live, there are some advantages to a virtual conference.

Personalized medicine might be a realistic target in many specialties in the next decade, including pulmonology.

Recently, in a paper presented at theEuropean Respiratory Society International Congress 2020 (ERS 2020), researchers presented data showing adiponectin and leptin were significantly different between men and women, with higher levels found in female patients.

Lars L. Andersson, PhD, Karolinska Institute, said 1 of the objectives of the study was to get closer to personalized medicine in an effort to derive what treatments could be most effective in individual patients.

Andersson explained in an interview with HCPLive, the new study gives researchers a better understanding of the impact of sex and age on circulating adipokines.

The study included 55 patients with mild to moderate asthma, 72 patients with severe asthma, and 41 patients with COPD. Overall, the researchers found both adiponectin and leptin were highly affected by body mass index (BMI), another datapoint for personalized medicine.

In a subgroup analysis, they found the difference in adiponectin between women and men was smaller in lean patients, while the difference in leptin was smaller in obese patients.

While the study was important, in a normal year Andersson would be able to present it live to his colleagues. However, with the coronavirus disease 2019 (COVID-19) pandemic bringing conferences virtual Andersson was forced to adjust.

However, Andersson said the virtual format has some benefits.

Read the original:
Lars Andersson, PhD: The Future of Personalized Medicine for Asthma - MD Magazine

Read More...

Impact Analysis of COVID-19 on Proteomics Market Outlook 2020-2028 by Emerging Global Trends, Leading Companies, Future Growth, Revenue, and Demand…

Sunday, September 13th, 2020

The proteomics market is segmented on the basis of proteomics instrumentation technology such as protein microarray (biochips, microarray instruments), spectroscopy (Mass and NMR), X-ray crystallography, chromatography, electrophoresis, proteomics reagents, proteomics services (analytical lab services, protein identification, extraction, sequencing, data analysis, maintaining bioinformatics data bases). The market is driven by growing need of personalized medicines, new discoveries in the field of genomics, rise in funds for proteomics based research, growing research and development expenditure, advancement in technologies, new techniques, high output, high resolutions achiness and instruments have been developed, availability of private funds and rise in the Asian markets like China and Japan.

The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).

Request To Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10233569

The top 10 companies own 40 to 50 percent of the market. Proteomic instrumentation market is dominated by proteomic microarray, accounting for around 50% of the revenue followed by spectroscopy techniques. Proteomic reagents market is dominated by immunoassays.

The market is restrained by various factors such as: success ratio of the researches is not very high, limitations of personalized medicines and lengthy regulatory approval process, reduction in funds by the US government, which owes 40% of this market, highly expensive medicines, which are 1000 fold costlier than the normal medicines present in the market and research and market is limited to a few developed nations only.

Major opportunities for the market lie in the Asian markets where contract research organizations are on a rise. Proteomics is science with broad applications in the field of therapeutics and diagnostics. Growing R&D and emergence of new players will create more market opportunities. Major players in the proteomics market are Thermo Fischer scientific corporation, Agilent technologies, Luminex corporation, Sigma-Aldrich corporation, Danaher corporation, Bio-Rad corporation, Waters corporation, PerkinElmer, Affymetrix and others.

The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).

Request To Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10233569

Companies profiled

1. Genzyme Corporation2. Thermo Fischer scientific corporation3. Becton Dickinson and Co4. BG medicine5. Agilent technologies6. Luminex corporation7. Sigma-Aldrich corporation8. Danaher corporation9. Anaspec Inc10. Asterand PLC11. Applied biosystems Inc12. Bayer technology13. Bio-Rad corporation14. Waters corporation15. PerkinElmer16. Affymetrix17. GE healthcare18. Genesystems Inc19. Activx Biosciences Inc20. Amgen Inc21. Beckman coulter22. Biacore International AB23. Biocarta Inc24. Bruker biosciences25. Caliper Lifesciences26. Cellzome AG27. Commonwealth biotechnologies28. Digilab biovision GmBH29. Dionex Corp30. Dualsystems biotech AG

This Research Report covers

1. Historical data2. Revenue forecasts, growth rates and CAGR upto 20283. Industry Analysis4. Competitive Analysis5. Key geographic growth data6. In-depth profiling of companies

Request for Complete Report:https://www.kennethresearch.com/sample-request-10233569

Key Answers Captured in Report?

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations, and organizations with the aim of helping them to take prominent decisions. Our research library comprises more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both the macro level as well as micro-level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides a significant analysis of various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keeps a track of the international and domestic market for any economic changes impacting the products demand, growth, and opportunities for new and existing players.

Updated Research Report Available @Kenneth Research with impact analysis of COVID-19

Geospatial Imagery Analytics MarketNetwork Access Control MarketVisitor Management System MarketPenetration Testing MarketPower Distribution Unit (PDU) Market

See the original post:
Impact Analysis of COVID-19 on Proteomics Market Outlook 2020-2028 by Emerging Global Trends, Leading Companies, Future Growth, Revenue, and Demand...

Read More...

North America is expected to be the largest regional market for Cell Surface Markers – WhaTech

Sunday, September 13th, 2020

The global cell surface markers market is valued at an estimated USD 520 million in 2018 and is projected to reach USD 769 million by 2023, at a CAGR of 8.1%

Factors such as the increasing funding for life sciences research, high global prevalence of cancer, and growth in stem cell and neurobiology research are expected to drive the growth of this market in the coming years.

[140 Pages Report] The cell surface markers market is valued at an estimated USD 520 million in 2018 and is projected to reach USD 769 million by 2023, at a CAGR of 8.1% during the forecast period.

Cell Surface Markers Market by Product (Antibody, PCR Array), Source (Mice, Rat), Cell Type (T cells, B cells, NK cell), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)), and End User (Hospitals) - Global Forecast to 2023

What drives the Market?

The increasing number of R&D activities and the growing use of cell surface markers in personalized medicine and drug discovery & development.

Download a PDF Brochure @ http://www.marketsandmarkets.com/pdfdown=216278622

North America is expected to be the largest regional market for cell surface markers

Market growth in North America, the largest regional market for cell surface markers, is primarily driven by the increasing number of R&D activities and the growing use of cell surface markers in personalized medicine and drug discovery & development. However, the market in Asia is estimated to grow at the highest CAGR during the forecast period.

The high growth of the Asian market can be attributed to the increasing number of life sciences research activities and government initiatives to boost the biotechnology and pharmaceutical industries in several Asian countries.

Key Market Players

The cell surface markers market is highly fragmented in nature, with several big as well as emerging players. Prominent players in this market include Thermo Fisher Scientific (US), QIAGEN N.V.

(Netherlands), Becton, Dickinson and Company (US), F. Hoffman-La Roche (Switzerland), Bio-Rad Laboratories (US), Danaher Corporation (US), Abcam (UK), GenScript (China), BioLegend (US), Cell Signaling Technology (US), Merck KGaA (Germany), and Bio-Techne (US).

Abcam is one of the prominent players operating in the cell surface markers market. The strong position of the company in this market can be attributed to its robust product portfolio.

The company has a strong geographical presence in the European and Asia Pacific markets with its manufacturing facilities in the UK, Japan, and China. The company also has significant market presence in the US and Latin America.

Thermo Fisher Scientific is another leading player in the cell surface markers market. The companys strong brand recognition and extensive product portfolio in this market are its key strengths.

To maintain its leading position in the market, the company adopts organic as well as inorganic growth strategies such as acquisitions and expansions.

Request a Sample Pages @ http://www.marketsandmarkets.com/request=216278622

Recent Developments

This email address is being protected from spambots. You need JavaScript enabled to view it.

Continue reading here:
North America is expected to be the largest regional market for Cell Surface Markers - WhaTech

Read More...

Page 30«..1020..29303132..40..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick